HLA-E and chronic myelogenous leukemia, BCR-ABL1 positive: To our knowledge, this is the first report that describes a possible association between higher susceptibility to CML relapse and HLA-E*0103 homozygosis, which highlights the usefulness of this allele as biomarker.